Skip to content
TREVENTIS™ Corporation
  • Home
  • About Us
    • Board of Directors
    • Advisory Board
  • Pipeline
    • Dual Aβ/ tau oligomer inhibitor
    • Broad spectrum TDP oligomer inhibitor
    • p53 oligomer inhibitor
  • Technology
    • Protein Misfolding: The Basics
    • Treventis’ CCM Technology
  • Therapeutic Areas
    • Alzheimer’s Disease and Tauopathy
    • Amyotrophic Lateral Sclerosis (ALS)
    • Parkinson’s Disease
    • Cancer
  • News & Publications
    • News
    • Publications
    • Social Media
  • Careers
  • Partners & Collaborators
  • Contact Us
TREVENTIS™ Corporation
TREVENTIS™ Corporation > News
  • Share
             
  • Print

Archives: News

Treventis scientists and advisors attend and present at ALS/MND 2020

Treventis scientists Drs. Christopher Barden and Ross Mancini and SAB member Dr. […]

Treventis attends Virtual AAIC 2020

Treventis was well represented at the Alzheimer Association International Conference, running from […]

Treventis founders awarded funding for COVID-19 clinical trial

LifeArc, a major UK-based charity, has announced funding for Treventis founders Dr. […]

Treventis attends Virtual BIO Conference

Not to be deterred by COVID-19, Treventis attended the BIO Digital International […]

Treventis attends 8th Neurodegenerative Drug Development Summit

Treventis CSO Mark Reed was in attendance at the 8th Neurodegenerative Drug […]

Treventis Attends Tau2020 Conference

Treventis VP Research Marcia Taylor has attended Tau2020 in Washington, DC, which […]

Treventis founders publish new computational methodology for brain drug design

Treventis founders Dr. Donald Weaver, Mark Reed, and Christopher Barden have supervised […]

Treventis attends BioPort Atlantic Conference

Treventis CEO Christopher Barden attended BioPort, Atlantic Canada’s largest health and life […]

Treventis gives invites presentation at Texas Life Science Forum

Treventis CSO Mark Reed attended the Texas Life Science Forum on November […]

Treventis attends the 2nd Neuromuscular Drug Development Summit (NMD)

CEO Christopher Barden attended the NMD Summit in Boston, Massachusetts, where he […]

Posts navigation

Previous 1 2 3 4 Next

Recent Comments

    Archives

    Categories

    • No categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Quick Links

    • Home
    • About Us
    • Contact Us

    Social Links

    • Twitter
    • Linkedin
    Copyright © Treventis Corporation. | Site Map
    Website by Axxiem